Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-DOTATATE PET Scan for Neuroendocrine Tumors
NCT02038738Phase 2Unknown
- Sponsor
- Ochsner Clinic Foundation
- Start
- Mar 2014
- Primary completion
- Mar 2019
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gallium ga 68 dotatate in Neuroendocrine Neoplasm (NEN), sponsored by Ochsner Clinic Foundation. Status: unknown.
02
Drugs
gallium ga 68 dotatate
03
Conditions
Neuroendocrine Neoplasm (NEN)
Beyond the preview
Go deeper on NCT02038738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02038738.